Impaired neutralisation of SARS-CoV-2 delta variant in vaccinated patients with B cell chronic lymphocytic leukaemia

BACKGROUND: Immune suppression is a clinical feature of chronic lymphocytic leukaemia (CLL), and patients show increased vulnerability to SARS-CoV-2 infection and suboptimal antibody responses. METHOD: We studied antibody responses in 500 patients following dual COVID-19 vaccination to assess the ma...

Descripción completa

Detalles Bibliográficos
Autores principales: Parry, Helen, McIlroy, Graham, Bruton, Rachel, Damery, Sarah, Tyson, Grace, Logan, Nicola, Davis, Chris, Willett, Brian, Zuo, Jianmin, Ali, Myah, Kaur, Manjit, Stephens, Christine, Brant, Dawn, Otter, Ashley, McSkeane, Tina, Rolfe, Hayley, Faustini, Sian, Richter, Alex, Lee, Sophie, Wandroo, Farooq, Shafeek, Salim, Pratt, Guy, Paneesha, Shankara, Moss, Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8743056/
https://www.ncbi.nlm.nih.gov/pubmed/35000597
http://dx.doi.org/10.1186/s13045-021-01219-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8743056/
https://www.ncbi.nlm.nih.gov/pubmed/35000597
http://dx.doi.org/10.1186/s13045-021-01219-7

Ejemplares similares